Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial.

Long-term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104-week VERTIS MET trial. — المؤلف: Gallo, Silvina — Diabetes, obesity & metabolism 20200907

المؤلف
Gallo, Silvina
النشر
Diabetes, obesity & metabolism 20200907
الوصف
1027-1036 p.
الموضوعات
Aged؛ Blood Glucose؛ Bone Density؛ Bridged Bicyclo Compounds, Heterocyclic؛ Diabetes Mellitus, Type 2؛ Double-Blind Method؛ Female؛ Glycated Hemoglobin